BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23861216)

  • 21. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
    Fragasso A; Ciancio A; Mannarella C; Gaudiano C; Scarciolla O; Ottonello C; Francone M; Nardella M; Peluso A; Melpignano A; Veglio MR; Quarta G; Turchetti C
    Eur J Intern Med; 2011 Feb; 22(1):62-5. PubMed ID: 21238896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
    Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration.
    Berdoukas V; Dakin C; Freema A; Fraser I; Aessopos A; Bohane T
    Haematologica; 2005 May; 90(5):685-6. PubMed ID: 15921384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
    Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
    Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
    Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y
    Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
    Li CG; Liu SX; Mai HR; Wang Y; Wen FQ; Liu RY; Zhang XH; Chu WC; Au WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb; 14(2):110-3. PubMed ID: 22357467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.
    Pfeifer CD; Schoennagel BP; Grosse R; Wang ZJ; Graessner J; Nielsen P; Adam G; Fischer R; Yamamura J
    J Magn Reson Imaging; 2015 Jul; 42(1):196-203. PubMed ID: 25236606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload in reticuloendothelial systems of pediatric oncology patients who have undergone transfusions: MR observations.
    Emy PY; Levin TL; Sheth SS; Ruzal-Shapiro C; Garvin J; Berdon WE
    AJR Am J Roentgenol; 1997 Apr; 168(4):1011-5. PubMed ID: 9124106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
    Meloni A; Restaino G; Missere M; De Marchi D; Positano V; Valeri G; Giuseppe D'Ascola D; Peluso A; Caterina Putti M; Lendini M; Giovanna Neri M; Midiri M; Sallustio G; Pepe A
    Am J Hematol; 2015 Sep; 90(9):E189-90. PubMed ID: 26044155
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
    Kaushik N; Eckrich MJ; Parra D; Yang E
    Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic iron loading predicts cardiac iron loading in thalassemia major.
    Noetzli LJ; Papudesi J; Coates TD; Wood JC
    Blood; 2009 Nov; 114(19):4021-6. PubMed ID: 19726718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major.
    Papakonstantinou O; Alexopoulou E; Economopoulos N; Benekos O; Kattamis A; Kostaridou S; Ladis V; Efstathopoulos E; Gouliamos A; Kelekis NL
    J Magn Reson Imaging; 2009 Apr; 29(4):853-9. PubMed ID: 19306409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise performance in thalassemia major: correlation with cardiac iron burden.
    Sohn EY; Kato R; Noetzli LJ; Gera A; Coates T; Harmatz P; Keens TG; Wood JC
    Am J Hematol; 2013 Mar; 88(3):193-7. PubMed ID: 23339082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.